Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Bonus News 3 Stocks You'll Wish You Bought Before 2026Written by Chris Markoch. Published 12/3/2025. 
Key Points - These three up-and-coming stocks have delivered triple-digit gains in 2025 and continue to show strong momentum.
- Key catalysts—including clinical milestones, revenue acceleration, and consumer demand—suggest more upside ahead.
- Analysts stay optimistic, with price targets suggesting possible double- or triple-digit gains from current levels.
Many investors profited from the artificial intelligence (AI) trade in 2025, but several up-and-coming stocks in other sectors have also posted impressive gains this year. The three stocks in this article remain small-cap names — the largest has a market cap just over $4 billion — yet each has made strong moves, illustrating that time in the market can beat trying to time the market. They wrote silver off as a "boring metal," but its move above $33 has forced analysts to reconsider what's really driving this market. With AI hardware, EVs, solar, and next-gen electronics all dependent on silver — while global supply continues to lag — this quiet setup is starting to look like one of the most overlooked opportunities in the commodities space.
Most investors still haven't connected the dots, which is why this new silver forecast guide breaks down the fundamentals behind the move, the real pressure building beneath the surface, and the steps to consider before silver becomes front-page news. Get the Silver Forecast Now If investors could see the future with absolute clarity, investing would be easy. The future is rarely clear, and a bullish outcome is not guaranteed. Still, the charts speak for themselves: investors who bought these names and held through rough patches are reaping rewards today, and the stocks may not be finished moving higher. Biotech Breakthrough: A Small Cap With a Big 2026 FDA Catalyst Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology company that recently delivered positive clinical data for its first-in-class PI3K/mTOR inhibitor targeting HR+/HER2- metastatic breast cancer. The company's pivotal Phase 3 VIKTORIA trial is underway, and some expect U.S. Food & Drug Administration (FDA) approval could come in 2026. Investors have been front-running those results, sending CELC stock up more than 660%, with nearly all of those gains occurring since late July. At $99.30 as of this writing, the stock sits within about 3% of its consensus price target. Jefferies raised its price target on Dec. 2 to $134 from $108. The largest risk is the cost of commercialization. In its most recent earnings report, Celcuity reported a strengthened balance sheet with $455 million in cash, cash equivalents, and short-term investments — up roughly 72% year-over-year (YOY). Management says that should be sufficient until commercialization begins. Fintech Disruptor Turning Revenue Growth Into Real Momentum At a time when many banks offer fewer options, Dave Inc. (NASDAQ: DAVE) makes a compelling case. The Los Angeles–based fintech is known for its Dave app, which provides affordable, transparent tools that help users—often living paycheck to paycheck—avoid overdraft fees, budget more effectively, and access short-term cash when needed. The company recently reported 64% YOY revenue growth and an 85% beat in adjusted earnings per share (EPS). DAVE stock is up 120% in 2025, and analysts see further upside. As of this writing the stock traded at $208.24, while the consensus price target is $304.25 — more than 46% higher. Some investors may balk at a forward price-to-earnings (P/E) ratio near 119x. However, analysts forecast earnings growth of over 117% in the next 12 months; that level of growth could justify the valuation if it materializes. Resale Retail Winner Riding a Massive Consumer Shift It's been another tough year for consumer staples stocks, but ThredUp Inc. (NASDAQ: TDUP) has been a notable exception. TDUP stock is up more than 430% in 2025, despite a roughly 29% sell-off in the three months ending Dec. 1. ThredUp operates as an online consignment marketplace, positioning it well as many consumer budgets remain stretched. The thrift and resale market was a $49 billion industry in 2024 and is expected to grow to $74 billion by 2029. TDUP is the smallest of the three names on this list, and short interest above 17% indicates active trader interest. Still, the company's Q3 report showed strong YOY revenue growth and, importantly, record new-buyer acquisition and a 37% YOY increase in orders. This could be a shorter-term trade for some investors. However, the younger consumers that form ThredUp's core market are likely to remain budget-conscious for some time, which helps explain why analysts assign a consensus price target of $12.50 — roughly a 68% upside from its Dec. 1 close.
| 
